由于激素、基因遗传等多方面原因,女性抑郁症发病率高于男性,大约是男性的1.2~2倍。目前,科学界围绕这一现象已经展开了大量研究,并有了一些初步结论。在女性抑郁症的治疗领域,越多越多的新疗法开始从激素角度着力,不过大部分仍处于研究阶段。 目前,在抑郁症的药物方面,SSRI、五羟色胺和去甲肾上腺素再摄取抑制剂(SNRI)都是最主流的药物,在国内几乎占据了约90%的抗抑郁药市场。 [1] https://www./articles/s41467-021-27604-x [2] https://www./articles/d41586-022-02213-w#ref-CR7 [3] https://www./diseases-conditions/depression/in-depth/depression/art-20047725 [4] https://www.nimh./health/topics/women-and-mental-health [5] https://www./articles/why-so-many-middle-aged-women-are-on-antidepressants-11648906393 [6] https://www.cas.cn/xw/kjsm/gjdt/200207/t20020712_1005938.shtml [7] https:///journals/jama/fullarticle/195120 [8] https://www./doi/full/10.1056/nejmp1514242 [9] https://www./science/article/abs/pii/S0006322322014007 [10] https://www./journals/ebiom/article/PIIS2352-3964(17)30139-1/fulltext [11] https:///article/society/2022/deal-work-stress-recover-burnout [12] https://www./articles/why-doctors-are-studying-new-drugs-to-treat-womens-midlife-mood-swings-11666566466 [13] https://www./articles/s41467-021-27604-x [14] https://www./article/fda-approves-first-new-drug-developed-for-women-with-postpartum-depression/ [15] https://mp.weixin.qq.com/s/Rs5n41LNls_E5cP6XOzW8w [16] https://bynews./zhxw/2021/16ec63da9d21454cb209756b422b11cd.htm [17] https://mp.weixin.qq.com/s/bHVtYjYQ-JXwxzVxUE_ICg [18] https://www.nimh./news/science-news/2019/bench-to-bedside-nimh-research-leading-to-brexanolone-first-ever-drug-specifically-for-postpartum-depression 关注《知识分子》视频号 制版编辑 | 姜丝鸭 |
|